Webinar · Palm Beach, Florida

Laboratory Developed Tests under FDA's Thumb - webinar by Compliance4all

Education, Training · Biology

Next editionNot confirmedLast edition we have: 10 Mar 2015
Last venueOnlineWebinar
RunningSince 2015Frequency unknown · 1 edition on record
Last checked12 Nov 2026Its old website no longer answers
We haven't confirmed the next dates yet. The last edition in our records was 10 Mar 2015 at Webinar Venue. Its old website no longer answers, so the show may have ended or moved. Are you the organiser? Correct this listing.

Key numbers

Editions on record
1first in 2015

About Laboratory Developed Tests under FDA's Thumb - webinar by Compliance4all

Overview:
The webinar clarifies the regulatory concern that FDA has and whether subjecting Laboratory Developed Tests (LDTs) to FDA's device Quality System Regulation can make a measurable difference in the safety and effectiveness (reliability) of special IVDs. The arguments on both sides of the issue will be identified and how regulation may adversely impact the quality of health care we have today. The presumption by FDA is that regulation will improve these special IVDs and, thereby, improve the quality of health care.

You will learn how reporting regulations, such as FDA's manufacturing regulations (Quality System Regulation (21 CFR Part 820)), Medical Device Reporting (21 CFR Part 803) and Reports of Corrections and Removals (21 CFR Part 806) would apply to LDTs. Once you identified the regulatory obligations, the logistical issues will be discussed and the types of game plans that may be necessary.

Why Should you Attend: FDA has edged closer and closer to regulating IVDs developed in laboratories rather than by a typical manufacturer registered with the FDA. Public debate pits an initiative for imposing standardized regulatory controls against decades of using laboratory-developed tests by licensed clinicians. This brings to mind some very practical questions? How do physicians change the logistics of their practice? How can clinical institutions provide specialized care when their tools are taken away? FDA regulation hammers specialized medical practices by throwing the process into a regulatory mill. A test developed by the doctor would now require production by manufacturer, who is subject to layers and layers of regulatory controls. As a consequence, there is no useful or timely turn around for supplying special in vitro reagents. Can the doctor order, receive and use a special reagent the same day now?

Healthcare institutions treatment protocols and purchasing contracts will require a massive overhaul. Do physicians aban

From our listing of this edition. Details may have changed since.

Editions

YearDatesWhereExhibitorsVisitors
201510 Mar 2015Webinar Venue
Online
——

Past editions from the bvents archive (2008–2019) and organiser figures where they were published.

Questions

When is Laboratory Developed Tests under FDA's Thumb - webinar by Compliance4all?

The next dates haven't been confirmed. The last edition we have on record was 10 Mar 2015.

Where is it held?

The last edition we have was at Webinar Venue, Palm Beach, Florida.

Who organises it?

Compliance4All.

Industries